Emtricitabine and tenofovir disoproxil fumarate
- Generic Name
- Emtricitabine and tenofovir disoproxil fumarate
- Indication
适用于与其他抗逆转录病毒药物联用，治疗成人和12岁（含）以上儿童的 HIV-1感染。
Demonstration Project of PrEP Among Female Sex Workers in Dakar, Senegal
- First Posted Date
- 2015-06-17
- Last Posted Date
- 2018-04-12
- Lead Sponsor
- Réseau Africain de Recherche sur le SIDA
- Target Recruit Count
- 267
- Registration Number
- NCT02474303
- Locations
- 🇸🇳
Centre de santé de Mbao, Dakar, Senegal
🇸🇳Centre de Santé de Rufisque, Dakar, Senegal
🇸🇳Centre de Santé Dominique de Pikine, Dakar, Senegal
PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV
- First Posted Date
- 2015-03-27
- Last Posted Date
- 2018-02-19
- Lead Sponsor
- Emory University
- Target Recruit Count
- 86
- Registration Number
- NCT02401230
- Locations
- 🇺🇸
The Hope Clinic of of Emory University, Decatur, Georgia, United States
PrEP With TDF/FTC to Prevent HIV-1 Acquisition in Young MSM and Transgender Women of Color
- Conditions
- HIV
- First Posted Date
- 2015-02-20
- Last Posted Date
- 2016-10-11
- Lead Sponsor
- Philadelphia Fight
- Target Recruit Count
- 50
- Registration Number
- NCT02367807
- Locations
- 🇺🇸
Philadelphia FIGHT, Philadelphia, Pennsylvania, United States
Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2018-01-19
- Lead Sponsor
- Emory University
- Target Recruit Count
- 4
- Registration Number
- NCT02333045
- Locations
- 🇺🇸
Grady Infectious Diseases Clinic (Ponce Clinic), Atlanta, Georgia, United States
🇺🇸Grady Memorial Hospital, Atlanta, Georgia, United States
Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy Volunteers
- First Posted Date
- 2014-10-01
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 33
- Registration Number
- NCT02253901
Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Adolescents
- First Posted Date
- 2014-08-11
- Last Posted Date
- 2023-07-03
- Target Recruit Count
- 148
- Registration Number
- NCT02213328
- Locations
- 🇿🇦
Desmond Tutu HIV Foundation Non-Network CRS, Cape Town, South Africa
🇿🇦Perinatal HIV Non-network Research CRS, Soweto, South Africa
PrEP Demonstration Project (PRELUDE Study)
- First Posted Date
- 2014-08-01
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- Kirby Institute
- Target Recruit Count
- 327
- Registration Number
- NCT02206555
- Locations
- 🇦🇺
St Vincent's Hospital HIV, Immunology and Infectious Disease Unit, Darlinghurst, New South Wales, Australia
🇦🇺RPA Sexual Health, Camperdown, New South Wales, Australia
🇦🇺Sydney Sexual Health Centre, Sydney, New South Wales, Australia
Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in India
- First Posted Date
- 2014-05-28
- Last Posted Date
- 2018-10-11
- Lead Sponsor
- University of Manitoba
- Target Recruit Count
- 1325
- Registration Number
- NCT02148094
- Locations
- 🇮🇳
DMSC Clinic, Kolkata, West Bengal, India
🇮🇳Ashodaya Samithi clinic, Mysore, Karnataka, India
Pre-exposure Option for Reducing HIV in the UK.(PROUD)
- Conditions
- HIV
- Interventions
- First Posted Date
- 2014-02-19
- Last Posted Date
- 2017-01-05
- Lead Sponsor
- MRC [ycm]
- Target Recruit Count
- 544
- Registration Number
- NCT02065986
- Locations
- 🇬🇧
MRC Clinical Trials Unit, London, United Kingdom
Pre-Exposure Prophylaxis (PrEP) Adherence Monitoring Using Dried Blood Spots
- First Posted Date
- 2013-12-30
- Last Posted Date
- 2019-04-30
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 52
- Registration Number
- NCT02022657
- Locations
- 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States
🇺🇸University of California San Francisco/San Francisco Department of Public Health, San Francisco, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.